RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, KARNATAKA
RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, KARNATAKA BANGALORE
ANNEXURE – II
PROFORMA FOR REGISTRATION OF SUBJECTS FOR DISSERTATION
|1. |Name of the candidate & Address |IZHAR KASID SHAIKH ABDUL GAFFAR |
| |(In block letters) |C/O LUQMAN COLLEGE OF PHARMACY, |
| | |POST BOX NO: 86, BEHIND P & T COLONY, |
| | |OLD JEWARGI ROAD, |
| | |GULBARGA – 585102 |
|2. |Name of the Institution |LUQMAN COLLEGE OF PHARMACY, GULBARGA-585102 |
|3. |Course of study and subject |M.PHARM (PHARMACEUTICS) |
|4. |Date of admission to course |20 MAY 2009 |
|5. |Title of the topic |FORMULATION AND EVALUATION OF BILAYER TABLET OF LISINOPRIL AND GLICLAZIDE |
|6. 6.1 |Brief resume of the intended work |
| |Need for the study : |
| |In recent times, various developed and developing countries move towards combination therapy for treatment of various diseases and disorders |
| |requiring long term therapy such as hypertension and diabetes. Combination therapy have various advantages over monotherapy such as problem of |
| |dose dependent side effects is minimized, a low dose combination of two different agents reduces the dose related risk, the addition of one |
| |agent may potentiate effects of other agent. Using low dosage of two different agents minimizes the clinical and metabolic side effects that |
| |occur with maximal dosage of individual component of the combined tablet and thus dose of the single components can be reduced1. Bilayer tablets|
| |are novel drug delivery systems where combination of two or more drugs in a single unit having different release profiles improves patient |
| |compliance, prolongs the drugs action, avoid saw tooth kinetics resulting in effective therapy along with better control of plasma drug level. |
| |Bilayer tablet are very common dosage form for drugs such as captopril, metoprolol, amoxicillin and potassium clavuanate, propranolol |
| |hydrochloride, bambuterol hydrochloride2. JNC VI recognized the value of combination therapy and suggested that combining drug with different |
| |modes of action will often allow smaller doses of drugs to be used to achieve control and minimize the potential dose dependent side effects. |
| |JNC VI recommended that the combination of a low dose of two drugs in fixed dose combination is an appropriate choice for initial treatment of |
| |any chronic disease3. Hypertension occurs with twice the frequency in diabetic compared with non diabetic population and upto 50% of patient |
| |with type-II diabetes mellitus became hypertensive. Therefore hypertension is one of the major risk factor for diabetic nephropathy and possibly|
| |for diabetic retinopathy. Angiotensin converting enzyme(ACE) inhibitor have been particularly recommended in patient with nephropathy as they |
| |decrease protienuria and preserve glomerular filtration rate in diabetic patient and they also potentiate the effect of sulphonyl urea and |
| |biguanides4. |
| |Lisinopril is an ACE inhibitors which is widely used in the treatment of hypertension in diabetic patients and also play a vital role in the |
| |management of diabetes complication such as diabetic nephropathy. Half life of lisinopril is 11-12 hours and given in a dose of 2.5–10 mg |
| |daily5. Gliclazide is a second generation sulphonyl urea, an antihyperglycemic agent that improves glucose tolerance and enhances peripheral |
| |insulin sensitivity in patient with type-II diabetics. Also the effect of gliclazide is potentiated by the lisinopril. Half life of gliclazide |
| |is 10-12 hours and given in a dose of 80 mg daily6. |
| |Hence in the present work an attempt will be made to formulate bilayer tablet of lisinopril and gliclazide as bimodal release system to manage |
| |diabetes mellitus and to overcome diabetic induced complications such as hypertension and nephropathy. |
| | |
|6.2 |Review of literature: |
| |Extensive literature survey was carried out on the proposed research work by referring various scientific journals, internet and helinet |
| |facilities. |
| |Yeole PG et.al1., study proved that bilayer tablet technology could be successfully used for the management of cardiovascular diseases by fixed |
| |dose combination of sustained release metoprolol tartarate and immediate release hydrochlorothiazide. Nagaraju R and Kaza R2., formulate and |
| |evaluate bilayer sustained release tablet of salbutamol and theophylline using polymer such as HPMC K4M, HPMC K100M, xanthum gum, ethyl |
| |cellulose and HPMC-P. Atram SC et.al3., prepared bilayer tablets of antihypertensive drugs and concluded that drug release of amlodipine |
| |besylate and metoprolol succinate follow non fickian diffusion and super class II transport. Shirwaikar AA et.al7., prepared sustained release |
| |bilayer tablet of diltiazem using insoluble matrix system and concluded that bilayer tablets shows bimodal release of diltiazem HCl. Chandira MR|
| |et.al8., worked on design, development and evaluation of immediate release atorvastatin and sustained release gliclazide tablet using two grades|
| |of HPMC and explained that combination of both drug in the form of bilayered tablet can be used effectively for the treatment of diabetes in |
| |obese patient. Nirmal J et.al9., formulate and evaluate bilayer tablet of Atorvastatin calcium as immediate release and nicotinic acid as |
| |sustained release for the treatment of hyperlipidemia. Amrutkar JR et.al10., formulate bilayer tablet of metformin and gliclazide for the |
| |treatment of diabetes and concluded that combination of hydrophilic and hydrophobic polymer with melt granulation technique is an excellent cost|
| |effective technique for achieving sustained release pattern. Uttam M et.al11., formulated and optimized bilayer antidiabetic matrix tablet |
| |containing metformin HCl and glipizide for the effective management of diabetes mellitus. Patra CN et.al12., design and evaluate sustained |
| |release bilayer tablets of propranolol HCl and concluded that bilayer tablet showed an initial burst effect to provide loading dose followed by |
| |sustained release. |
| | |
|6.3 |Objectives of the Study |
| | |
| |The aim of the present work is to formulate and evaluate bilayer tablet of lisinopril and gliclazide with the following objectives: |
| | |
| |Preparation of immediate release layer of Lisinopril using superdisintegrants by direct compression methods. |
| |Preparation of sustained release layer of Gliclazide by using hydrophilic, synthetic and semisynthetic polymer by wet granulation method. |
| |Compression of immediate release layer and sustained release layer to make a bilayer tablet. |
| |Physicochemical characterization of bilayer tablet by IR spectroscopy. |
| |Evaluation of tablet parameter such as hardness, thickness, friability, weight variation, drug content, for both immediate release and sustained|
| |release layer separately. |
| |In Vitro release study of immediate release and sustained release layer separately. |
| | |
|7. |Material and Methods |
| | |
| |Materials : |
| |The materials to be used in the present studies include, |
| |Drug : Lisinopril (Antihypertensive) |
| |Gliclazide (Antidiabetics) |
| |Polymer : |
| |For immediate release layer: - Super disintegrants like sodium starch glycolate, cross carmellose sodium etc. |
| |For sustained release layer: -Synthetic and semi synthetic hydrophilic polymer like sodium carboxy methyl cellulose, hydroxyl propyl methyl |
| |cellulose, hydroxyl propyl cellulose. |
| |Equipments : |
| |UV/ Visible spectrophotometer (Shimadzu 1700) |
| |IR – spectrophotometer – JASCO FT/IR 5300 |
| |Single Pan electronic balance (Dhona equipment pvt ltd Kolkata) |
| |Digital balance (Shimadzu corporation BL-2204) |
| |Digital type pH meter (elico LT122) |
| |Electrolab dissolution apparatus (USPXIII) |
| |Tablet compression machine (Rimek) |
| |Monsanto Hardness tester. |
| |Roche Friability apparatus |
| |Hot air oven |
| | |
|7.2 |Methods : |
| | |
| |UV spectrophotemetric estimation of Lisinopril drug. |
| |UV spectrophotemetric estimation of Gliclazide. |
| |Immediate release layer will be prepared using different superdisintegrant by Direct Compression Method. |
| |Sustained release layer will be prepared by wet granulation method. |
| |Evaluation of tablet parameter like hardness, thickness, friability, weight variation, drug content and in vitro dissolution studies for both |
| |layers separately. |
| | |
|7.3 |Does the study require any investigation or intervention to be conducted on patients or other humans or animals? If so, please describe |
| |briefly. |
| |----------- Not under the plan of our work ----------------- |
|7.4 |Has ethical clearance been obtained from your institution in case of 7.3? |
| |------------ Not applicable --------------- |
|8. |List of Reference |
| |Yeole PG, Karande AD, Dhoke SV. Formulation and evaluation of bilayer tablet with antihypertensive drugs having different release pattern. Ind |
| |Drugs.2006; 43(1): 44-50. |
| |Nagaraju R, Kaza R. Formulation and evaluation of bilayer sustained release tablets of salbutamol and theophylline. Int J Pharma Sci |
| |NanoTech.2009;2(3):638 -.646. |
| |Atram SC et.al., Formulation of bilayer tablet containing metoprolol succinate and amlodipine besylate for antihypertensive therapy. J Pharm |
| |Research.2009;2(8):1335-1347. |
| |Sweetman SC (Eds), Martindale:The complete drug reference, 33rd edition. Great Britain, Pharmaceutical press.2002: 322,921. |
| | |
| | |
| |Shirwaikar AA, shrinatha A. Sustained release bilayer tablet of diltiazem hydrochloride using insoluble matrix system. Ind J Pharm |
| |Sci.2004;6(4):433-437. |
| |Chandira MR, Jayakar B, Pashupathi A, Chakrabarty BL, Maurya P. Design, development and evaluation of immediate release atorvastatin and |
| |sustained release gliclazide tablets. J Pharm Research.2009;2(6):1039-1041. |
| |Nirmal J et.al., Bilayer Tablets of Atorvastatin Calcium and Nicotinic Acid: Formulation and Evaluation,. Chem Pharm Bull.2008;56(10):1455 |
| |-1458. |
| |Amrutkar JR, Kasalkar MG, Shrivastav VG, Yeole PG. Bilayer tablet formulation of metformin hydrochloride and Gliclazide: A novel approach in the|
| |treatment of diabetics. Int J Pharm Research Dev.2009;1(5):7-15. |
| |Mandal U, Pal TK. Formulation and in vitro studies of a fixed dose combination of a bilayer matrix tablet containing metformin as sustained |
| |release and glipizide as immediate release.Drug Dev Ind Pharm.2008;(34):305-313. |
| |Patra CN, Arethi BK, Pandit HK, Singh SP. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride. Acta |
| |Pharm.2007;57:479–489. |
| |Kartheikeyini CS, Jayaprakash S, Abirami A, Halith MS. Formulation and evaluation of aceclofenac sodium bilayer sustained release tablets. Int J|
| |ChemTech Research.2009;1(4):1381-1385. |
| |Shiyani B, Gattani S, Surana S. Formulation and evaluation of bilayer tablet of metaclopramide hydrochloride and ibuprofen. AAPS |
| |PharmSciTech.2008;9(3):818-827. |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|9. |Signature of Candidate | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |[IZHAR KASID SHAIKH] |
|10. | Remarks of Guide | |
| | | |
| | | |
| | | |
| | | |
|11. | Name & Designation of (in block letters) | |
| | | |
| | | |
| | | |
| | | |
| | | |
| |11.1. Guide |MR. M.A. SALEEM |
| | |ASST. PROFESSOR, |
| | |DEPARTMENT OF PHARMACEUTICS, |
| | |LUQMAN COLLEGE OF PHARMACY, |
| | |GULBARGA. |
| |11.2. Signature | |
| | | |
| | | |
| |11.3 Co-Guide |aeJAZ ahmed |
| | |m. pharm |
| | |LECTURER, |
| | |LUQMAN COLLEGE OF PHARMACY, |
| | |GULBARGA. |
| |11.4 Signature | |
| | | |
|12. |12.1 Remark of the Chairman and Principal | |
| | | |
| | | |
| | | |
| |12.2 Signature | |
| | | |
| | | |
| | | |
| | | |
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- archives of biological sciences journal
- definition of social sciences pdf
- blackrock health sciences fact sheet
- list of social sciences degrees
- blackrock health sciences trust
- blackrock health sciences stock
- archives of biological sciences impact
- institute of mathematical sciences chennai
- university of natural health scam
- university of texas health system
- university of tampa health center
- university of medical sciences ondo